Respiratory Medicine
Volume 95, Issue 1 , Pages 78-82, January 2001

The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures

Methodist Le Bonheur Healthcare, Memphis, TN, U.S.A.

Received 4 August 2000; accepted 12 October 2000.

Abstract 

The value of blood cultures in community-acquired pneumonia (CAP) has been questioned. At issue is the potential for blood cultures to change management. We prospectively studied the yield and impact of blood cultures in patients admitted with CAP. Two hundred and nine subjects had at least two blood cultures prior to receiving antibiotics. The severity of CAP was graded using the Pneumonia Severity Index (PSI). Twenty-nine patients (13·9%) had a pathogen identified by blood culture. The yield of blood cultures increased with PSI grade (I—5·3%, II—10·2%, III—10·3%, IV—16·1%, V—26·7%), as did the likelihood of blood cultures changing antibiotic therapy (I to III 0%, IV—9·7%, V—20·0%). One hundred and seventy-nine (85·6%) patients received a quinolone, limiting the impact of pathogens resistant to β -lactams. Four of 16 patients (25·0%) with a culture (blood or sputum)-guided change in antibiotic therapy died, compared to five of 31 patients (16·1%) who had an empiric change. Blood cultures are of minimal value in mild to moderate CAP, and should be limited to patients with PSI grade IV or V CAP unless a specific risk factor for pathogens resistant to the empiric therapy is present.

Keywords: community-acquired pneumonia, blood cultures.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Correspondence should be addressed to: Dr Waterer, Methodist Le Bonheur Healthcare, 1265 Union Ave, 501 Crews Wing, Memphis, TN 38104-2499, U.S.A. Fax: +1-901-726-2456; E-mail: waterer@attglobal.net

PII: S0954-6111(00)90977-6

doi:10.1053/rmed.2000.0977

Respiratory Medicine
Volume 95, Issue 1 , Pages 78-82, January 2001